Alston & Bird health care partner Cathy Burgess spoke about how the Food & Drug Administration’s (FDA) quality metrics initiative for pharmaceutical companies may also impact expectations for device manufacturers down the line. Click here to listen.
In the News
December 9, 2015
Cathy Burgess Discusses FDA Quality Metrics Initiative with The Gray Sheet (Audio)
Media Contact